{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~6 mi. (Santa Cruz, California, +825 more cities)
facility
Palo Alto Medical Foundation-Santa Cruz
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
S0820, Adenoma and Second Primary Prevention Trial
city
~6 mi. (Santa Cruz, California, +616 more cities)
facility
Palo Alto Medical Foundation-Santa Cruz
condition
Colon Carcinoma, +1 more condition
drug
eflornithine, +2 more drugs
drug type
chemotherapy, +1 more type
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~6 mi. (Santa Cruz, California, +469 more cities)
facility
Palo Alto Medical Foundation-Santa Cruz
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
city
~6 mi. (Santa Cruz, California, +413 more cities)
facility
Palo Alto Medical Foundation-Santa Cruz
drug
ipilimumab, +2 more drugs
drug type
immunotherapy, +1 more type